⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21645654 | 0.72 | — | — | |
| SCHEMBL137063 | 0.72 | — | — | |
| SCHEMBL3111439 | 0.72 | — | — | |
| SCHEMBL5573210 | 0.72 | — | — | |
| SCHEMBL2421724 | 0.72 | — | — | |
| SCHEMBL4758979 | 0.72 | — | — | |
| SCHEMBL11612430 | 0.72 | — | — | |
| SCHEMBL183750 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL23120283 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL9180393 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0616973-A1 | Process for removing excess acid from acidic hydroxylamine salt solution | Sachem, Inc. (US) | 1994-09-28 | — | — | EP | claimed |
| US-5281311-A | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-25 | — | — | US | claimed |
| EP-0577100-A1 | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-05 | — | — | EP | claimed |
| US-5259934-A | Process for removing acid from a hydroxylamine salt solution containing excess acid | SACHEM, INC. (US) | 1993-11-09 | — | — | US | claimed |
| WO-2023279760-A1 | METHOD FOR DETECTING CONTENT OF POLYVINYL ALCOHOL BY MEANS OF SPECTROPHOTOMETRY | 珠海联邦制药股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| US-20140206701-A1 | SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2014-07-24 | — | — | US | disclosed |
| WO-2011023706-A1 | PROCESS FOR THE PREPARATION OF A GLUCOKINASE ACTIVATOR COMPOUND | F. HOFFMANN-LA ROCHE AG (CH) | 2011-03-03 | — | — | WO | disclosed |
| WO-2010062264-A1 | LIPOPEPTIDE COMPOUNDS AND THEIR USE | MERLION PHARMACEUTICALS PTE LTD (SG) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010025272-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING TOXICITY AND TREATING OR PREVENTING DISEASES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2010-03-04 | — | — | WO | disclosed |
| WO-2008152068-A2 | [1,10]-PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES | NOSCIRA, S.A. (ES) | 2008-12-18 | — | — | WO | disclosed |
| EP-2002863-A1 | [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases | NOSCIRA, S.A. (ES) | 2008-12-17 | — | — | EP | disclosed |
| WO-2008057282-A1 | CALCIUM RECEPTOR MODULATING AGENTS | AMGEN INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2007002214-A2 | ACYL GUANIDINES AS BETA-SECRETASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2005040161-A1 | BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS | S*BIO PTE LTD (SG) | 2005-05-06 | — | — | WO | disclosed |
| US-6258518-B1 | AN AROMATIC OXY, NITRILE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-10 | — | — | US | disclosed |
| EP-0616973-A1 | Process for removing excess acid from acidic hydroxylamine salt solution | Sachem, Inc. (US) | 1994-09-28 | — | — | EP | disclosed |
| US-5281311-A | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0577100-A1 | Process for reducing the acid content of hydroxylamine salt solutions and for preparing hydroxylamines from hydroxylamine salts | SACHEM, INC. (US) | 1994-01-05 | — | — | EP | disclosed |
| US-5259934-A | Process for removing acid from a hydroxylamine salt solution containing excess acid | SACHEM, INC. (US) | 1993-11-09 | — | — | US | disclosed |